Australian Biotech Bionomics Acquires Biogen-Idec Spin-off Eclipse Therapeutics
This article was originally published in PharmAsia News
Executive Summary
Aussie biotech Bionomics acquires Eclipse Therapeutics, which is developing drug candidates that target cancer stem cells.